ARQT

Arcutis Biotherapeutics (ARQT)

About Arcutis Biotherapeutics (ARQT)

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

Details

Daily high
$15.77
Daily low
$14.18
Price at open
$14.18
52 Week High
$15.79
52 Week Low
$2.96
Market cap
1.8B
Dividend yield
0.00%
Volume
5.2M
Avg. volume
2.3M
P/E ratio
-8.36

Arcutis Biotherapeutics News

Details

Daily high
$15.77
Daily low
$14.18
Price at open
$14.18
52 Week High
$15.79
52 Week Low
$2.96
Market cap
1.8B
Dividend yield
0.00%
Volume
5.2M
Avg. volume
2.3M
P/E ratio
-8.36